Pocock S J, Lagakos S W
Br J Cancer. 1982 Sep;46(3):368-75. doi: 10.1038/bjc.1982.212.
The results from an international survey of 15 major cancer centres have clarified how randomization is being implemented in cancer trials. As regards the mechanics of obtaining treatment assignment for each patient a system of telephone registration to a central randomization office was widely used. We also advise formal checks for patient eligibility immediately before treatment assignment, and subsequent written confirmation of randomization to the investigators. As regards statistical methods, stratification of randomization by one or two prognostic factors (and institution in multicentre trials) is commonplace. Most centres used the standard approach of random permuted blocks within strata though some others used "dynamic" institution-balancing or "minimization" methods instead. The value of stratified allocation is chiefly for the trial's credibility in having comparable treatment groups, rather than for statistical efficiency. One should avoid overstratification and use only the really important prognostic factors. One essential is that randomization should in practice work for every patient, so undue complexity is to be avoided.
一项针对15个主要癌症中心的国际调查结果,阐明了癌症试验中随机分组是如何实施的。关于为每位患者获取治疗分配的具体操作,广泛采用的是向中央随机分组办公室进行电话登记的系统。我们还建议在进行治疗分配前,对患者的入选资格进行正式核查,并随后向研究者提供随机分组的书面确认。在统计方法方面,根据一个或两个预后因素(以及多中心试验中的机构)进行随机分组分层是很常见的。大多数中心在各层内采用标准的随机排列区组方法,不过也有一些中心采用“动态”机构平衡或“最小化”方法取而代之。分层分配的价值主要在于使试验具有可比性治疗组,从而提高试验的可信度,而非提高统计效率。应避免过度分层,只使用真正重要的预后因素。一个关键要点是,随机分组在实际操作中应对每位患者都有效,因此应避免过度复杂。